{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:45:04Z","timestamp":1787003104517,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The demonstration of MJFR14-6-4-2 proximity ligation assay positive aggregates in brains affected by Parkinson\u2019s disease and LRRK2 mutations, motivated the analysis of \u03b1-synuclein oligomers in brain cytosol from dementia with Lewy bodies (DLB) and control cases by combining size-exclusion chromatography, aggregate-specific MJFR14-6-4-2 ELISA and SDS-denaturing immunoblotting. We demonstrate a DLB-specific accumulation of large SDS-soluble oligomers, and the presence of medium-sized oligomers consisting of SDS-resistant \u03b1-synuclein dimers and trimers in both DLB and controls.<\/jats:p>","DOI":"10.1038\/s41531-026-01301-2","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:53:42Z","timestamp":1772258022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Higher-molecular-weight a-synuclein oligomers are increased in the brain cytosol of patients with dementia with Lewy bodies"],"prefix":"10.1038","volume":"12","author":[{"given":"Emil","family":"Gregersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia R.","family":"Antorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Zaccagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poul Henning","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3233\/JPD-179009","volume":"7","author":"AB Singleton","year":"2017","unstructured":"Singleton, A. B., Hardy, J. A. & Gasser, T. The birth of the modern era of Parkinson\u2019s disease genetics. J. Parkinsons Dis. 7, S87\u2013s93 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"1301_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00441-017-2706-9","volume":"373","author":"MG Spillantini","year":"2018","unstructured":"Spillantini, M. G. & Goedert, M. Neurodegeneration and the ordered assembly of \u03b1-synuclein. Cell Tissue Res. 373, 137\u2013148 (2018).","journal-title":"Cell Tissue Res."},{"key":"1301_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng, C., Gathagan, R. J. & Lee, V. M. Distinct \u03b1-synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies. Neurobiol. Dis. 109, 209\u2013218 (2018).","journal-title":"Neurobiol. Dis."},{"key":"1301_CR4","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1301_CR5","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"1301_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature 610, 791\u2013795 (2022).","journal-title":"Nature"},{"key":"1301_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. USA 97, 571\u2013576 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1301_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey, B. & Lansbury, P. T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267\u2013298 (2003).","journal-title":"Annu. Rev. Neurosci."},{"key":"1301_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jnc.14808","volume":"150","author":"P Alam","year":"2019","unstructured":"Alam, P., Bousset, L., Melki, R. & Otzen, D. E. \u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities. J. Neurochem. 150, 522\u2013534 (2019).","journal-title":"J. Neurochem."},{"key":"1301_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","volume":"329","author":"N Cremades","year":"2017","unstructured":"Cremades, N., Chen, S. W. & Dobson, C. M. Structural characteristics of \u03b1-synuclein oligomers. Int. Rev. Cell Mol. Biol. 329, 79\u2013143 (2017).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"1301_CR11","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1002\/anie.201710779","volume":"57","author":"JA Varela","year":"2018","unstructured":"Varela, J. A. et al. Optical structural analysis of individual \u03b1-synuclein oligomers. Angew. Chem. Int. Ed. Engl. 57, 4886\u20134890 (2018).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1301_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"DW Dickson","year":"1999","unstructured":"Dickson, D. W. et al. Widespread alterations of alpha-synuclein in multiple system atrophy. Am. J. Pathol. 155, 1241\u20131251 (1999).","journal-title":"Am. J. Pathol."},{"key":"1301_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon, R. et al. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron 37, 583\u2013595 (2003).","journal-title":"Neuron"},{"key":"1301_CR14","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1074\/jbc.C113.538249","volume":"289","author":"N Gould","year":"2014","unstructured":"Gould, N. et al. Evidence of native \u03b1-synuclein conformers in the human brain. J. Biol. Chem. 289, 7929\u20137934 (2014).","journal-title":"J. Biol. Chem."},{"key":"1301_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou, K. E. et al. Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132, 1093\u20131101 (2009).","journal-title":"Brain"},{"key":"1301_CR16","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/brain\/awv040","volume":"138","author":"RF Roberts","year":"2015","unstructured":"Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson\u2019s disease brain. Brain 138, 1642\u20131657 (2015).","journal-title":"Brain"},{"key":"1301_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41531-024-00841-9","volume":"10","author":"NM Jensen","year":"2024","unstructured":"Jensen, N. M. et al. MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity. npj Parkinsons Dis. 10, 227 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1301_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00401-025-02871-w","volume":"149","author":"NM Jensen","year":"2025","unstructured":"Jensen, N. M. et al. Abundant non-inclusion \u03b1-synuclein pathology in Lewy body-negative LRRK2-mutant cases. Acta Neuropathol. 149, 41 (2025).","journal-title":"Acta Neuropathol."},{"key":"1301_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","volume":"137","author":"H Sekiya","year":"2019","unstructured":"Sekiya, H. et al. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol. 137, 455\u2013466 (2019).","journal-title":"Acta Neuropathol."},{"key":"1301_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00401-025-02872-9","volume":"149","author":"H Sekiya","year":"2025","unstructured":"Sekiya, H. et al. Widespread distribution of \u03b1-synuclein oligomers in LRRK2-related Parkinson\u2019s disease. Acta Neuropathol. 149, 42 (2025).","journal-title":"Acta Neuropathol."},{"key":"1301_CR21","doi-asserted-by":"publisher","first-page":"fcaa010","DOI":"10.1093\/braincomms\/fcaa010","volume":"2","author":"JB Sanderson","year":"2020","unstructured":"Sanderson, J. B. et al. Analysis of \u03b1-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies. Brain Commun. 2, fcaa010 (2020).","journal-title":"Brain Commun."},{"key":"1301_CR22","doi-asserted-by":"publisher","first-page":"e0196056","DOI":"10.1371\/journal.pone.0196056","volume":"13","author":"LB Lassen","year":"2018","unstructured":"Lassen, L. B. et al. ELISA method to detect \u03b1-synuclein oligomers in cell and animal models. PLoS ONE 13, e0196056 (2018).","journal-title":"PLoS ONE"},{"key":"1301_CR23","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M306390200","volume":"279","author":"E Lindersson","year":"2004","unstructured":"Lindersson, E. et al. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem. 279, 12924\u201312934 (2004).","journal-title":"J. Biol. Chem."},{"key":"1301_CR24","doi-asserted-by":"publisher","first-page":"21500","DOI":"10.1074\/jbc.M000099200","volume":"275","author":"PH Jensen","year":"2000","unstructured":"Jensen, P. H. et al. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J. Biol. Chem. 275, 21500\u201321507 (2000).","journal-title":"J. Biol. Chem."},{"key":"1301_CR25","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1046\/j.1460-9568.1999.00754.x","volume":"11","author":"PH Jensen","year":"1999","unstructured":"Jensen, P. H., Li, J. Y., Dahlstrom, A. & Dotti, C. G. Axonal transport of synucleins is mediated by all rate components. Eur. J. Neurosci. 11, 3369\u20133376 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"1301_CR26","doi-asserted-by":"crossref","unstructured":"Burai, J. Am. Chem. Soc. 137, 5041\u20135052 (2015).","DOI":"10.1021\/ja5131726"},{"key":"1301_CR27","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla, E. et al. Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo. J. Neurosci. 32, 3301\u20133305 (2012).","journal-title":"J. Neurosci."},{"key":"1301_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41531-024-00822-y","volume":"10","author":"I Liekni\u0146a","year":"2024","unstructured":"Liekni\u0146a, I. et al. Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2. npj Parkinsons Dis. 10, 206 (2024).","journal-title":"npj Parkinsons Dis."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01301-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01301-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:59:40Z","timestamp":1775728780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01301-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01301-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7957852\/v1","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}